EFFECTIVENESS OF ORAL RUXOLITINIB FOR ACUTE GVHD PROPHYLAXIS AFTER HAPLOIDENTICAL BONE MARROW TRANSPLANTATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA: A PHASE Ⅱ,SINGLE-CENTER, SINGLE-COHORT, PROSPECTIVE CLINICAL TRIAL
EHA Library, Yang Yan,
419417
EXPLORING THE PSYCHOLOGICAL EXPERIENCES AND NEEDS OF HAPLOIDENTICAL STEM CELL DONORS DONATING TO A PARENT OR AN ADULT CHILD: RESULTS OF A UK, MULTICENTER, QUALITATIVE STUDY
EHA Library, Rosalina Naidoo,
419455
PREDICTORS OF SURVIVAL AND SUCCESSFUL RESPONSE TO UPFRONT UC-MSC TREATMENT IN ACUTE GVHD PATIENTS: FINDINGS FROM A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED MULTICENTRE CLINICAL TRIAL
EHA Library, Sen Mui Tan,
419458
BRIQUILIMAB POTENTLY INHIBITS SCF/C-KIT SIGNALING, WHICH DOES NOT INDUCE HEALTHY HUMAN HEMATOPOIETIC STEM CELL (HSC) APOPTOSIS, BUT SKEWS HSC DIFFERENTIATION POTENTIAL.
EHA Library, Hye-Sook Kwon,
419478